Scientists Discover Why Animal Studies May Lead To Ineffective ALS Drugs
A five year study of more than 70 drugs, many with reported survival benefit in a mouse model of the inherited form of amyotrophic lateral sclerosis — ALS or Lou Gehrig’s Disease, concluded the apparent positive effects were largely due to previously unrecognized variables in the study design, scientists reported. The study included the drug riluzole, the only drug approved by the U.S. Food and Drug Administration for ALS treatment.
More: continued here
Filed under: Muscular Dystrophy on January 29th, 2008